HCRT and insomnia measurement: Orexin antagonists like suvorexant, which is currently approved for the treatment of insomnia, are being evaluated for the treatment of SUD, as the effect of orexin could be of help in attenuating drug rewards and improving sleep disturbances by preventing the potentiation of reward and arousal [17,18].